Saudi Arabia Decided To Develop Astrazeneca And Pfizer Vaccine Locally

KEY POINTS

• Saudi health officials have closed the Corona vaccine center in the eastern region, where most Saudis and expatriates have received both vaccine doses.
• Saudi Arabia is expecting to sign agreements with international pharmaceutical companies to develop Astrazeneca And Pfizer Vaccine Locally.
• The goal of the Ministry of Health is to get more than 70% of the country’s population vaccinated and to strengthen the immune system of society.

Vaccine Centers In East Regions Closing After Most Of The Population Of That Area Vaccinated:

Speaking to Al-Arabiya Channel, Huda Al-Mahini, a member of Al-Sharqiya Health Complex, said that many vaccination centres have been closed down in our country. Was equal to

Huda al-Mahini added that 50 percent of the country’s population had received both doses of the vaccine.

Al-Mahini said that many vaccination centers are now open where people 12 years of age and older arrive for the vaccine.

The goal of the Ministry of Health is to get more than 70% of the country’s population vaccinated and to strengthen the immune system of the society.

Al-Arabiya channel showed the closure of the vaccination center under Amir Muhammad bin Fahd Hospital in Qatif – where the center was no longer needed.

Saudi Arabia Signed An Agreement With International Pharmaceutical Companies To Develop Covid-19 Vaccines Locally:

Saudi Arabia is expecting to sign agreements with international pharmaceutical companies to develop coronavirus vaccines locally.

As part of the Riyadh International Summit for Medical Technology activities, pharmaceutical companies AstraZeneca and Pfizer will develop vaccines locally.

Al-Sharq has said that the Riyadh International Summit will start on Tuesday in Riyadh.

It will get attended by the Ministers of Finance, Investment, Health, and Industry.

“Memorandums of Understanding will get signed with pharmaceutical companies and several companies in the field of medical technology and the Ministries of Investment and Health,” the source told Al-Sharq.

The meeting will discuss scientific topics, such as challenges related to medical biotechnology in Saudi Arabia, investment strategies for medical biotechnology, and biotechnology’s role in developing medicines, vaccines, and cellular and genetic therapies.